Publications
- Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance2018 | Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma2018 | Second Faculty of Medicine, First Faculty of Medicine
- Minimal residual disease – detection possibilities in haematological and non-haematological malignancies2013 | Second Faculty of Medicine
- Quantitative PCR detection of NPM/ALK fusion gene and CD30 gene expression in patients with anaplastic large cell lymphoma - Residual disease monitoring and a correlation with the disease status2008 | Second Faculty of Medicine
- Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring2006 | Second Faculty of Medicine
- Array-based analysis of gene expression in childhood acute lymphoblastic leukemia2004 | Second Faculty of Medicine
- Impact of TEL/AML1-positive patients on age distribution of childhood acute lymphoblastic leukemia in Czech republic1998 | Second Faculty of Medicine
- A 5-year-old boy with super-refractory status epilepticus and RANBP2 variant warranting life-saving hemispherotomy2024 | Second Faculty of Medicine, Central Library of Charles University
- Molecular Screening in ALK-Positive Anaplastic Large Cell Lymphoma: ALK Analysis, NGS Fusion Gene Detection, and T-cell Receptor Immunoprofiling2024 | Second Faculty of Medicine, Third Faculty of Medicine
- Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group2024 | Second Faculty of Medicine, Third Faculty of Medicine
Loading network view...
